Methods

Patient Inclusion Criteria
A retrospective study was performed in all patients who underwent transnasal TSS at our department be tween January 2007 and August 2009. A total of 145 op erations, excluding revision operations, were performed in 141 patients by the senior author (R.L.B.). At our de partment, olfactory testing is performed as part of the clinical evaluation in patients who are scheduled to have TSS. All patients who received preoperative olfactory testing were included in the evaluation. These criteria led to a final group of 96 patients who answered questions concerning nasal obstruction, underwent examination of the nasal septum, and were retested in regard to olfactory function at followup evaluation.
Preoperative Assessment
All 96 patients underwent preoperative testing of ol factory performance in our department or at our local ear, nose, and throat department. Testing was done with the Sniffin' Sticks olfactory test (Burghart Medizintechnik) or Zürcher Geruchstest (www.novimed.ch). In olfactory testing, both sides were investigated simultaneously. Cor rect recognition of more than 85% of presented odors was defined as normal, between 85% and 50% as hyposmic, and below 50% as anosmic. The nasal septum was ex amined at the beginning of each operation by the senior author.
Surgical Technique
Microsurgery was performed in the PoleStar N20 ap paratus (0.15 T, www.medtronic.com) by means of a di rect transnasal transsphenoidal approach. Following oro tracheal induction of anesthesia, the patient was placed in a supine position with the head reclined and fixed in the head holder. The nasal cavities were packed for 3-5 min utes with gauze soaked in a mixture of 30 ml 2% tetracaine HCl and 2 mg adrenaline. Nostrils and surrounding skin were then disinfected with iodine solution. After draping, a selfretaining nasal speculum (www.aesculap.com) was placed in the nasal cavity, typically the narrower one, and the anterior sphenoid wall was visualized with the aid of the operating microscope. The posterior part of the septal bone was then fractured toward the opposite side by lever age with the speculum, and the mucosa was incised in an inverted T shape with a disc knife. The first speculum was withdrawn, and a Buchfelder pituitary speculum (www. dewimed.de) was inserted and fixed in position. After that, the anterior sphenoid wall was removed with punches or a chisel to gain access to the sphenoid sinus. Finally, the sellar pathological entity was removed, without postopera tive packing of the nasal cavities.
Postoperative Treatment and Follow-Up
Following the operation, a CT scan was obtained to rule out postoperative complications, and patients were observed daily for fluid and electrolyte balance, epistaxis, nasal dripping, and visual acuity. Acromegaly was consid ered cured if the GH serum level dropped below 1 mg/L, as defined in the acromegaly treatment consensus work shop. 1, 10 Patients with epistaxis were clinically examined if the bleeding was immediately pronounced or if it did not subside within 1 to 2 days of surgery. Postoperative nasal crusting and/or clotting was gently resolved using an isotonic, sterile, saltwater nose spray (Triomer spray, Vifor AG) 3-4 times daily.
After discharge, patients typically received clinical follow-up and underwent MR imaging 3 months postop eratively, and thereafter in yearly intervals. At followup, the patients' subjective perception of postoperative nasal breathing ability was assessed in comparison with before surgery. Furthermore, nasal septum defects were evaluated using rhinoscopy, and olfactory performance was tested only with the Zürcher Geruchstest by the senior author.
Statistical Analysis
At each olfactory testing session, the number of cor rectly assigned odors was transformed into an olfactory performance rate, with a range of 0%-100%. Statistical testing was performed using the PASW Statistics 18 pro gram. For cross-tabulation, we used the Fisher exact test because of small cell counts. Because our data cannot be assumed to be normally distributed, we applied nonpara metric testing: the Mann-Whitney test for comparisons between groups and the paired Wilcoxon signed-ranks test for before and after comparisons within groups. All tests were 2-sided, and the significance level was set at 0.05.
Results
Patient Demographic Data
In the 32month period, 96 patients who underwent 98 direct transnasal transsphenoidal operations were included in this study. The age range was 11.9-86.7 years (mean 53.1 years). There were 62 male and 34 female patients. Two participants had repeated surgery within these 32 months: a 19-year-old woman with recurrence of a GH-producing macroadenoma, and a 50yearold man with recurrent Rathke cyst. The cohort included 72 macroadenomas, 11 microadenomas, 9 Rathke cysts, and 1 each of meningio ma, craniopharyngioma, arachnoid cyst, and oncocytoma. Among the adenomas were 41 hormoneinactive and 42 hormoneactive tumors. Of the 96 patients, 23 (24%) had acromegaly; 18 of them were considered cured according to the definition of the acromegaly consensus workshop, 1, 10 4 had normal serum GH levels (but > 1 mg/L), and 1 dis played an elevated level of 6.2 mg/L at follow-up. Over all there were 17 recurrent tumors (18%), 16 of which had been previously treated transsphenoidally (Table 1) and 1 transcranially at another center. Follow-up duration ranged from 3 to 34 months (mean 10.3 months).
Olfactory Performance
Preoperatively, 39 (41%) of 96 patients displayed nor mal smelling capability, 53 (55%) had hyposmia, and 4 (4%) were anosmic. Postoperatively, 60 (62%) of 96 pa tients had normal olfactory performance, 30 (31%) were hyposmic, and 6 (6%) had anosmia. Comparing pre and postoperative performance of each patient, we found 15 (16%) of 96 to have experienced no change in their smell ing capability (unchanged group), 47 (49%) were able to discriminate more odors (improved group), and 34 (35%) had deteriorated in their ability to distinguish the tested substances (deteriorated group).
Comparing the groups with improved, deteriorated, and unchanged olfaction divided according to the underly ing disease, we noticed a remarkable difference between the 23 patients with acromegaly and the 73 others. Among the patients with acromegaly, 15 (65%) of 23 improved, 3 (13%) deteriorated, and 5 (22%) remained unchanged. The values differ remarkably from the patients without acro megaly, of whom 32 (44%) of 73 improved, 31 (42%) de teriorated, and 10 (14%) remained unchanged. The num bers are illustrated in Fig. 1 . Based on these numbers, we constructed a table for the categories "olfaction improved/ unchanged/deteriorated" and "acromegalic/nonacromega lic," and found a significant difference for the effect of sur gery between the 2 patient groups (Fisher exact test; p = 0.028). This difference between the groups was confirmed by a nonparametric comparison (Mann-Whitney test; p = 0.025). We then compared olfactory performance rates pre and postoperatively within each group (paired Wilcoxon test). A significant improvement was only found in the ac romegalic group (p = 0.009), and not in the nonacromega lic group (p = 0.9). This is reflected in the median change of olfactory performance in the 2 groups: acromegalic (8%, range from -16% to 33%), and nonacromegalic (0%, range from -67% to 63%). This reflects a change of noticeable magnitude pointing toward its clinical relevance.
Nasal Airway Patency
Unaffected, normal nasal respiration was reported in 77 (80%) of 96 cases. Better nasal air passage was re ported in 11 (12%) of 96 cases, and 8 (8%) of 96 patients expressed reduced patency after the operation. Two of these 8 experienced an overall reduced ability to breathe through their nose, whereas 3 each were able to state the side of dominant obstruction. In the 11 cases with better postoperative air passage, 6 patients (55%) had GH-pro ducing adenomas and 1 patient had a correction of a nasal septal deviation in combination with the TSS.
Surgery affected the airway patency of patients with and without acromegaly differently. Of the patients with acromegaly, 3 (13%) of 23 deteriorated, 13 (57%) remained unchanged, and 7 (30%) improved. Of the nonacromegalic patients, 5 (7%) of 73 deteriorated, 64 (88%) remained un changed, and 4 (6%) improved. The difference between pa tient groups was significant (Fisher exact test; p = 0.002). 
Septal Perforation
Among the 96 patients, we found 2 perforations at the time of surgery: one was in a patient with known cocaine abuse, and the other was in a patient who had undergone 3 prior TSSs at other centers. The other 94 patients did not develop any perforations within the followup time.
Epistaxis Requiring Coagulation
We encountered severe or persistent epistaxis in 3 (3%) of 96 patients, who required transnasal surgical re vision with coagulation of the sphenopalatine artery. All 3 had undergone TSS for the first time.
Discussion
Olfactory Performance
A remarkable difference was found between patients with and without acromegaly in regard to olfactory per formance. In patients with acromegaly, 65% improved in olfactory performance, versus 44% of those without ac romegaly, and only 13% of patients with acromegaly de teriorated, versus 42% of those without the disease (Fig.  1) . We propose 2 mechanisms by which this improvement may occur. First, an entrapment mechanism in the olfac tory system, analogous to median nerve neuropathy, 7 may be reduced after successful treatment of acromegaly, lead ing to improved nerve function. Second, excessive GH production in patients with acromegaly is associated with hypertrophy of the nasal mucosa, 11 which consecutively congests the region below the cribriform plate. Reduced GH production after surgery may reverse this effect, thus enabling an improved interaction of aromatic molecules with the primary sensory neurons. This hypothesis is sup ported by the fact that 18 patients with acromegaly were cured, 4 had normal GH serum levels, and only 1 pre sented with persistent elevation of GH levels.
There is a limitation of our study in that we used the Sniffin' Sticks olfactory test to assess the patients pre operatively and the Zürcher Geruchstest for postopera tive followup. The change was motivated by the better robustness of the latter test in our followup setting. To compare between test results, we had to calculate per centages from the test results instead of using the scored number values. As a consequence, we confined the results to only 3 broad groups: normosmic, hyposmic, and anos mic, without trying to distinguish more subtle nuances in olfactory performance.
Comparison of our data on olfactory complications with existing literature is difficult, because olfactory per formance has hardly ever been systematically observed in patients who have undergone TSS. Higgins et al. 6 men tion a 2%-12% incidence of anosmia and hyposmia in pa tients treated with the transseptal approach. Koren et al. 8 found hyposmia and anosmia in 2 (10%) of 20 patients who had undergone transnasal endoscopic surgery, and Tan and Jones 12 report on 1 patient (4%) of 25 with hypos mia. Our results, with a 35% prevalence of postoperative olfactory deterioration, are based on the largest series to date. It must be considered that this high prevalence also accounts for subtle deterioration within the normosmic range, and only 6 patients were actually anosmic.
Nasal Airway Patency and Other Complications
Fairley et al. 4 have demonstrated a strong correlation between the subjective sensation of nasal patency and the objective nasal inspiratory peak flow rate. Consider ing this, we conducted a survey for postoperative reduced nasal airway patency, and found it in 8% of patients by questioning them. These results were similar to those of Tan and Jones, 12 who analyzed peak nasal inspiratory flow rates and found 3 (12%) of 25 patients with reduced nasal air passage. Griffith and Veerapen, 5 the pioneers of the di rect transnasal approach, observed a 3% diminishment of postoperative nasal breathing capability in their cohort of 100 patients. Again, in the analysis of this particular na sal complication, we registered a more than proportional percentage of patients with acromegaly (55%) among those who improved in nasal respiration. This further fortifies our assumption of decreasing mucosal hypertrophy after normalization of GH production as one of the factors lead ing to improvement of nasal function in these patients. Fur thermore, we postulate that the choice in the side of direct transnasal access may be beneficial for patients who pres ent with septal deviation. If the speculum is placed on the side that has greater obstruction due to the septal deviation, the amount of deviation may in part be corrected as a side effect of the direct transnasal approach.
No new perforations of the nasal septum as a result of the direct transnasal approach were observed. This find ing is comparable with prior studies in which the direct transnasal microsurgical resection of pituitary adenomas has been analyzed. 3, 12 In contrast to this, several authors applying an endoscopic approach reported a 5%-10% septal perforation rate. 6, 8 As mentioned by others, we suspect that this may be due to the increased mechanical manipulation within the nasal cavities during endoscopic pituitary surgery.
With a rate of approximately 3% for epistaxis re quiring revision surgery, this complication should not be underestimated. In all cases of epistaxis, hemorrhage occurred from branches of the sphenopalatine artery. Management consisted of monopolar cauterization of the bleeding artery in the sphenopalatine foramen, which in all cases was conducted successfully. Published rates of epistaxis range from 1% to 4%. 9, 12 Prior TSS performed via varying approaches does not present a contraindication for repeat direct transnasal TSS in cases of recurrent disease. In all of our 16 cases with prior TSS, in some of which the patients have un dergone multiple operations (Table 1) , the procedure was always accomplished successfully without a higher oc currence of nasal complications.
Conclusions
Our data provide the first significant evidence for im provement of olfactory performance in patients with ac romegaly after TSS of GH-producing adenomas. Further more, postoperative olfactory disturbance in transnasal TSS is more frequent than previously reported, when also accounting for subtle deterioration within the normosmic range. Nevertheless, recurrent transnasal TSS can be per formed successfully, even multiple times, and does not involve a higher risk of nasal complications.
